Table 2 Overall results comparing CHOP to MACOP-B/VACOP-B

From: Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B

 

CHOP

MACOP-B/VACOP-B

P

Patients

43

95

 

CR/NCR

22/43 (51.1%)

76/95 (80%)

P<0.001

PR

3/43 (6.9%)

10/95 (10.5%)

n.s.

NR/PD

18/43 (41.8%)

9/95 (9.4%)

P<0.001

REL

5/22 (22.7%)

7/76 (9.2%)

n.s.

EFS

17/43 (39.5%)

72/95 (75.7%)

P<0.001

Back to article page